Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Other Non Operating Income (2020 - 2026)

Maxcyte has reported Other Non Operating Income over the past 6 years, most recently at $1.6 million for Q4 2025.

  • Quarterly Other Non Operating Income fell 29.25% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, down 28.35% year-over-year, with the annual reading at $7.3 million for FY2025, 28.35% down from the prior year.
  • Other Non Operating Income was $1.6 million for Q4 2025 at Maxcyte, down from $1.7 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2.8 million in Q4 2023 and troughed at -$732500.0 in Q1 2021.
  • The 5-year median for Other Non Operating Income is $1.9 million (2022), against an average of $1.5 million.
  • Year-over-year, Other Non Operating Income soared 10506.52% in 2022 and then plummeted 30.57% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $80800.0 in 2021, then skyrocketed by 2302.35% to $1.9 million in 2022, then surged by 45.18% to $2.8 million in 2023, then decreased by 18.24% to $2.3 million in 2024, then fell by 29.25% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Other Non Operating Income are $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.9 million (Q2 2025).